Abstract
It has been shown that the direct modification of metabolic networks by means of gene transfection or, genetic engineering, can cause unnecessary stresses and the metabolic overloading of cells. As a consequence, negative effects such as a reduced proliferation rate and decrease in productivity can arise; it would be more desirable to select for these factors using a directional or artificial selection approach- which can be simply achieved by altering the phenotypic mean in a population. Several specific procedures have been developed to create cell lines with improved characteristics for mammalian cell production culture systems. Primarily, natural variants with higher growth rates and apoptosis-resistance attributes were isolated using; a limiting dilution procedure, cultivating clones from prolonged batch or, culturing cells that survived a ‘death-inducing’ environment. The selected variants were shown to be superior in their survival, growth and productivity characteristics as compared to the parental cells and other transfected ‘anti-apoptotic’/high producing variants. Stability was also maintained for prolonged periods of cultivation. This suggests the existence of natural variations in the NS0 cell line and that growth and apoptosis are selectable traits. Significant differences, as well as a negative relationship, for growth, apoptosis-resistance and productivity were identified- suggesting a fine balance exists between the advantageous use of transfection technology and any consequent effect(s) that it may cause.
Keywords
- Trypan Blue Exclusion Assay
- Recombinant Chinese Hamster Ovary Cell
- Animal Cell Technology
- Selected Clone
- Unnecessary Stress
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Al-Rubeai M, Singh RP. 1998. Apoptosis in cell culture. Current opinion in Biotechnology 9: 152–156
Bailey JE. 1991. Toward science of metabolic engineering. Science 252: 1668–1675
Barnes LM, Bentley CM, Dickson AJ. 1999. Advances in animal cell recombinant protein production: GS- NSO expression system. Cytotechnology 32: 109–123
Bebbington CR, Renner G, Thomson S, King D, Abrams D, Yarranton GT. 1992. High-level expression of a recombinant antibody from myeloma cells using glutamine synthetase gene as an amplifiable selectable marker. Bio Technology 10: 169–175
Bi J, Wirth M, Beer C, Zeng AP. 2002. Dynamic characterisation of recombinant chinese hamster ovaiy cells containing an inducible c-fos promoter GFP expression system as a bioniarker. Journal of Biotechnology 93: 231–241
Birch J, Boraston RC, Metcalfe H, Brown ME, Bebbington CR, Field RP. 1994. Selecting and designing cell lines for improved physiological characteristics. Cylotechnology 15: 11–16
Fussenegger M, Schlatter S. Datwyler D, Mazur X, Bailey JE. 1998. Controlled proliferation by multigene metabolic engineering enhances the productivity of chinese hamster ovary cells. Nature Biotechnology 16: 468–472
Gescher A. 1998 (Review). Analogs of staurosporine: potential anticancer drug?. Gen. Pharmac. 31:721–728 Glacken MW, Fleisehaker RJ, Sinskey AJ. 1986. Reduction of waste product excretion via nutrient control:
possible strategies for maximising product and cell yields on serum in cultures of mammalian cells. Biotech. Bioeng. 28: 1376–1389
LeBoeuf RA, Kerckaert GA. 1986. The induction of transformed-like morphology and enhanced growth in Syrian hamster embryo cells grown at acidic pH. Careinogenesis 7: 1431–1440
Mohan DRK, Nagarathna R, Krishna M, Jagtap JC, Shastry P. 1999. Differential responses of staurosporine on protein kinase C activity and proliferation in two murine neuroblastoma cell lines. Cancer Letters 139: 137–143
Osman JJ, Birch J, Varley J. 2001. The response of GS-NSO myeloma cells to pH shifts and perturbations. Biotechnology and Bioengineering 75: 63–73
Seaver SS. 1992. Enhancing monoclonal antibodies and hybridoma cell lines. Cytotechnology 9: 131–139
Simpson NH, Milner AE, Al-Rubeai M. 1997. Prevention of hybridoma cell death by bcl-2 during suboptimal conditions. Biotechnology and Bioengineering 54: 1–16
Simpson NH, Singh RP, Perani A, Goldenzon C, Al-Rubeai M. 1998. In hybridoma cultures, deprivation of any single amino acid leads to the induction of apoptosis, which is suppressed by the Bcl-2 gene. Biotechnology and Bioengineering 59: 90–98
Srivastava S, Katayose D, Tong YA, Craig C, McLeod D, Moul JW, Cowan KH, Seth P. 1995. Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation. Urology 46: 843–848
Stephanopoulos G and Sinskey AJ. 1993. Metabolic engineering- methodologies and future prospects. Tibtech 11: 392–396
Tey l3T, Singh RP, Piredda L, Piacentini M, Al-Rubeai M. 2000. Bcl-2 mediated suppression of apoptosis in myeloma NSO cultures. Journal of Biotechnology 79: 147–159
Watanabe S, Shuttleworth J, Al-Rubeai M. 2002. Regulation of cell cycle and productivity in NSO cells by the over-expression of p2l. Biotechnology and Bioengineering 77: 1–7
Yallop CA, Svendsen I. 2001. The effects of G418 on the growth and metabolism of recombinant mammalian cell lines, Cvtotechnologv 35: 101–114
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this paper
Cite this paper
Chau, D., Al-Rubeai, M. (2003). Artificial Selection of High Proliferating and Apoptosisresistant NS0 Cells for Industrial Production Systems. In: Yagasaki, K., Miura, Y., Hatori, M., Nomura, Y. (eds) Animal Cell Technology: Basic & Applied Aspects. Animal Cell Technology: Basic & Applied Aspects, vol 13. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0726-8_39
Download citation
DOI: https://doi.org/10.1007/978-94-017-0726-8_39
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6557-5
Online ISBN: 978-94-017-0726-8
eBook Packages: Springer Book Archive